Since IRAK1 is also important for NF-κB p65 activation, we propose that inhibition of IRAK1 may be another therapeutic strategy to regulate NF-κB p65 activation, as well as to simultaneously impede pro-tumorigenic and pro-inflammatory signaling in PCa. This evidence concerns the gene RELA and posterior cortical atrophy.